# ![@ADC_Chemist Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1517950670510301184.png) @ADC_Chemist ADCのケミスト

ADCのケミスト posts on X about $heide, daily, vivo, bond the most. They currently have [-----] followers and [---] posts still getting attention that total [---] engagements in the last [--] hours.

### Engagements: [---] [#](/creator/twitter::1517950670510301184/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1517950670510301184/c:line/m:interactions.svg)

- [--] Month [------] +1,929%
- [--] Months [------] +627%
- [--] Year [------] +58%

### Mentions: [--] [#](/creator/twitter::1517950670510301184/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1517950670510301184/c:line/m:posts_active.svg)

- [--] Months [--] +140%
- [--] Year [--] -83%

### Followers: [-----] [#](/creator/twitter::1517950670510301184/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1517950670510301184/c:line/m:followers.svg)

- [--] Month [-----] +0.35%
- [--] Months [-----] +7.80%
- [--] Year [-----] +32%

### CreatorRank: [---------] [#](/creator/twitter::1517950670510301184/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1517950670510301184/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[stocks](/list/stocks)  7.48% [technology brands](/list/technology-brands)  2.8% [finance](/list/finance)  0.93% [currencies](/list/currencies)  0.93%

**Social topic influence**
[$heide](/topic/$heide) #95, [daily](/topic/daily) 2.8%, [vivo](/topic/vivo) 1.87%, [bond](/topic/bond) 1.87%, [kymera](/topic/kymera) 0.93%, [novo](/topic/novo) 0.93%, [$5201t](/topic/$5201t) 0.93%, [ibm](/topic/ibm) 0.93%, [sanofi](/topic/sanofi) 0.93%, [acs](/topic/acs) 0.93%

**Top accounts mentioned or mentioned by**
[@simarakyobanana](/creator/undefined) [@goldph](/creator/undefined) [@souyakuchan](/creator/undefined) [@burigoki](/creator/undefined) [@kamokamos](/creator/undefined) [@mrnetinfo](/creator/undefined) [@buri_goki](/creator/undefined)

**Top assets mentioned**
[IBM (IBM)](/topic/ibm) [Sanofi (SNY)](/topic/sanofi) [Johnson & Johnson (JNJ)](/topic/johnson-johnson) [Terns Pharmaceuticals, Inc. (TERN)](/topic/$tern)
### Top Social Posts
Top posts by engagements in the last [--] hours

"Phase [---] KFA115HRO761NSCLCMGY825AAA802 AMO959GCJ904 https://www.biospace.com/business/novartis-cuts-6-early-cancer-candidates-adds-2-to-refine-oncology-strategyutm_campaign=33719445-2026%20%7C%20Daily%20Social&utm_content=368524124&utm_medium=social&utm_source=linkedin&hss_channel=lcp-424124 https://www.biospace.com/business/novartis-cuts-6-early-cancer-candidates-adds-2-to-refine-oncology-strategyutm_campaign=33719445-2026%20%7C%20Daily%20Social&utm_content=368524124&utm_medium=social&utm_source=linkedin&hss_channel=lcp-424124"  
[X Link](https://x.com/ADC_Chemist/status/2019746157694738729)  2026-02-06T12:13Z [----] followers, [----] engagements


"AAA802 Actinium-225 PSMA https://www.oncologypipeline.com/apexonco/novartis-prunes-its-pipeline https://t.co/qApjg2MLiX Phase [---] KFA115HRO761NSCLCMGY825AAA802 https://www.oncologypipeline.com/apexonco/novartis-prunes-its-pipeline https://t.co/qApjg2MLiX Phase [---] KFA115HRO761NSCLCMGY825AAA802"  
[X Link](https://x.com/ADC_Chemist/status/2019747407022456972)  2026-02-06T12:18Z [----] followers, [----] engagements


"ADCImmolative spacerTML-2Cl ADCImmolative spacer Val-Cit linkerPABC Immolative spacerTML TML3Thorpe-Ingoldgem- 2TML-2ClpKa PABC/PABEPayload Val-Cit-PABCCes1c In vivo https://www.sciencedirect.com/science/article/pii/S0223523426000851 https://www.sciencedirect.com/science/article/pii/S0223523426000851"  
[X Link](https://x.com/ADC_Chemist/status/2020097955030790662)  2026-02-07T11:30Z [----] followers, [----] engagements


"AmgenLilly2025Amgen650Lilly12 2004290002020-202414000 https://www.biospace.com/business/as-amgen-and-lilly-recommit-puerto-rico-seeks-to-regain-manufacturing-momentum https://www.biospace.com/business/as-amgen-and-lilly-recommit-puerto-rico-seeks-to-regain-manufacturing-momentum"  
[X Link](https://x.com/ADC_Chemist/status/2019252831652573510)  2026-02-05T03:32Z [----] followers, [----] engagements


"AmgenJuncos1993LillyCarolinaLilly del Caribe1960 Amgen Lily https://investor.lilly.com/news-releases/news-release-details/lilly-announces-more-12-billion-investment-puerto-rico-facility https://www.amgen.com/newsroom/press-releases/2025/09/amgen-announces-650m-expansion-of-us-manufacturing-creating-hundreds-of-new-jobs AmgenLilly2025Amgen650Lilly12 https://t.co/DUeXFWjuPH https://investor.lilly.com/news-releases/news-release-details/lilly-announces-more-12-billion-investment-puerto-rico-facility"  
[X Link](https://x.com/ADC_Chemist/status/2019253767313690988)  2026-02-05T03:36Z [----] followers, [----] engagements


"RNA2-OHSHAPE P3S P3153 https://t.co/fh0F1Jiu6S # #TCI2026 https://t.co/Mta1Smyccq P3S P3153 https://t.co/fh0F1Jiu6S # #TCI2026 https://t.co/Mta1Smyccq"  
[X Link](https://x.com/ADC_Chemist/status/2021162689733566488)  2026-02-10T10:01Z [----] followers, [----] engagements


"Sick leaveDr's appointment 🥺 😅 Tax return🥺Tax return🥺 . Tax return🥺Tax return🥺 "  
[X Link](https://x.com/ADC_Chemist/status/2022431495298986412)  2026-02-13T22:03Z [----] followers, [----] engagements


"CAR-TPoseida Therapeutics10 PoseidaCAR-T 😳 https://www.fiercebiotech.com/biotech/roche-inks-15b-poseida-buyout-betting-shelf-car-ts-will-democratize-access-cell-therapies https://www.fiercebiotech.com/biotech/roche-inks-15b-poseida-buyout-betting-shelf-car-ts-will-democratize-access-cell-therapies https://www.fiercebiotech.com/biotech/roche-inks-15b-poseida-buyout-betting-shelf-car-ts-will-democratize-access-cell-therapies https://www.fiercebiotech.com/biotech/roche-inks-15b-poseida-buyout-betting-shelf-car-ts-will-democratize-access-cell-therapies"  
[X Link](https://x.com/ADC_Chemist/status/1861701857032442302)  2024-11-27T09:21Z [----] followers, [----] engagements


"#Peing # https://peing.net/ja/qs/1188660438 https://peing.net/ja/qs/1188660438"  
[X Link](https://x.com/ADC_Chemist/status/1879451110580371616)  2025-01-15T08:50Z [----] followers, [----] engagements


"Xilio TherapeuticsT cell engagerTMEMMP https://xiliotx.com/scientific-approach#gps-platform https://xiliotx.com/scientific-approach#gps-platform"  
[X Link](https://x.com/ADC_Chemist/status/1889986921289711841)  2025-02-13T10:36Z [----] followers, [----] engagements


"Kymera TherapeuticsTPD TPDKT-333 [----] https://www.kymeratx.com/ https://www.kymeratx.com/ https://www.kymeratx.com/ https://www.kymeratx.com/"  
[X Link](https://x.com/ADC_Chemist/status/1908276391163928635)  2025-04-04T21:52Z [----] followers, [----] engagements


"ASCOZai LabADCMedilinkTAMALINADC TAMALIN https://www.businesswire.com/news/home/20250422666558/en/Zai-Lab-to-Present-Data-from-Phase-1-Trial-of-DLL3-Targeted-Antibody-Drug-Conjugate-ADC-ZL-1310-at-2025-ASCO-Annual-Meetingutm_campaign=shareaholic&utm_medium=twitter&utm_source=socialnetwork https://www.businesswire.com/news/home/20250422666558/en/Zai-Lab-to-Present-Data-from-Phase-1-Trial-of-DLL3-Targeted-Antibody-Drug-Conjugate-ADC-ZL-1310-at-2025-ASCO-Annual-Meetingutm_campaign=shareaholic&utm_medium=twitter&utm_source=socialnetwork"  
[X Link](https://x.com/ADC_Chemist/status/1925728135162585296)  2025-05-23T01:39Z [----] followers, [----] engagements


"AOCAntibody conjugatesAvidity BiosciencesDyne Therapeutics (182) #mond_Matsuda_PhDPhD https://mond.how/ja/topics/49uf11bs72no647/kf1v5a7oxtacatn https://mond.how/ja/topics/49uf11bs72no647/kf1v5a7oxtacatn"  
[X Link](https://x.com/ADC_Chemist/status/1927273372246847841)  2025-05-27T07:59Z [----] followers, [----] engagements


"Dual payloadBispecifc ADC412aMMAF+SN38 Tavotek BiotherapeuticsDual payloadBispecifc ADC EGFRcMETBispecific mAb412a2Payload (SN38 and MMAF)ADCPEG-Cleavable linker-PayloadSN38Val-CitMMAFSN38MMAFMono ADC ADCin vitroMono payload ADC412a-MMAF412a-SN38IC50 senescenceADCCDK4/6MEKPDACER+ In vivo1 mg/kgMono payload ADCDual payload ADCADC24089in vivo Dual payload x BisAb ADCADC https://www.mdpi.com/1999-4923/17/8/967 https://www.mdpi.com/1999-4923/17/8/967 https://www.mdpi.com/1999-4923/17/8/967 https://www.mdpi.com/1999-4923/17/8/967"  
[X Link](https://x.com/ADC_Chemist/status/1949420005927628984)  2025-07-27T10:42Z [----] followers, [----] engagements


"20254M&A 20NovartisAvidity Biosciences113 MerckCidara Therapeutics92 Novo NordiskAkero Therapeutics49 SanofiDynavax22 BioMarinAmicus Therapeutics48 [--] [--] https://www.biospace.com/business/big-pharma-dealmakers-joined-by-spunky-group-of-biotech-buyers-in-q4 https://www.biospace.com/business/big-pharma-dealmakers-joined-by-spunky-group-of-biotech-buyers-in-q4 https://www.biospace.com/business/big-pharma-dealmakers-joined-by-spunky-group-of-biotech-buyers-in-q4 https://www.biospace.com/business/big-pharma-dealmakers-joined-by-spunky-group-of-biotech-buyers-in-q4"  
[X Link](https://x.com/ADC_Chemist/status/2007185497739976831)  2026-01-02T20:21Z [----] followers, [----] engagements


"ADC CompanyTubulisRevolution MedicinesR&DSteve Kelsey KelseyADC20SutentPerjetaKadcylaErivedge ADCTUB-030: 5T4TUB-040: NaPi2b https://www.biospace.com/press-releases/tubulis-adds-steve-kelsey-as-independent-director-to-its-advisory-board https://www.biospace.com/press-releases/tubulis-adds-steve-kelsey-as-independent-director-to-its-advisory-board https://www.biospace.com/press-releases/tubulis-adds-steve-kelsey-as-independent-director-to-its-advisory-board https://www.biospace.com/press-releases/tubulis-adds-steve-kelsey-as-independent-director-to-its-advisory-board"  
[X Link](https://x.com/ADC_Chemist/status/2016352530402546004)  2026-01-28T03:27Z [----] followers, [----] engagements


"American Peptide Society: APS APS1990 https://americanpeptidesociety.org/ https://americanpeptidesociety.org/"  
[X Link](https://x.com/ADC_Chemist/status/2020465299229946294)  2026-02-08T11:50Z [----] followers, [----] engagements


"@SimarakyoBanana ADCTAK-188 https://aacrjournals.org/mct/article/22/9/1063/728670/S-531011-a-Novel-Anti-Human-CCR8-Antibody-Induces https://aacrjournals.org/mct/article/22/9/1063/728670/S-531011-a-Novel-Anti-Human-CCR8-Antibody-Induces"  
[X Link](https://x.com/ADC_Chemist/status/2020600433086255294)  2026-02-08T20:47Z [----] followers, [---] engagements


"Eli LillyOrna Therapeutics24in vivo CAR-T Eli LillyOrna Therapeutics24in vivo CAR TBOrnaOrna-252CD19CAR-TB https://www.biospace.com/business/eli-lilly-enters-car-t-realm-with-2-4b-orna-buy-starting-with-autoimmune https://www.biospace.com/business/eli-lilly-enters-car-t-realm-with-2-4b-orna-buy-starting-with-autoimmune"  
[X Link](https://x.com/ADC_Chemist/status/2021008237898891402)  2026-02-09T23:48Z [----] followers, [----] engagements


"https://jaxis-us.com/2026/02/11/26-2-million-employees-expected-to-miss-work-the-day-after-super-bowl/ https://jaxis-us.com/2026/02/11/26-2-million-employees-expected-to-miss-work-the-day-after-super-bowl/"  
[X Link](https://x.com/ADC_Chemist/status/2021788913044721859)  2026-02-12T03:30Z [----] followers, [---] engagements


"Convoy(San Diego)🙄 10🚗322Trader JoesWhole FoodsTargetRalphsWalmart Albertsons # # 10🚗322Trader JoesWhole FoodsTargetRalphsWalmart Albertsons # #"  
[X Link](https://x.com/ADC_Chemist/status/2022033164877877383)  2026-02-12T19:40Z [----] followers, [----] engagements


"BioMarin Pharmaceutical Inc. [--------] https://www.biospace.com/job-trends/biomarin-to-lay-off-225-employees-globally https://www.biospace.com/job-trends/biomarin-to-lay-off-225-employees-globally"  
[X Link](https://x.com/ADC_Chemist/status/1829334298497102334)  2024-08-30T01:44Z [----] followers, [----] engagements


"Charles River LaboratoriesCDMO20 CRO20262 CRL20257%202670001170 https://www.fiercebiotech.com/cro/charles-river-close-cell-therapy-cdmo-site-lay-20-staffers https://www.fiercebiotech.com/cro/charles-river-close-cell-therapy-cdmo-site-lay-20-staffers"  
[X Link](https://x.com/ADC_Chemist/status/2019010040469028931)  2026-02-04T11:27Z [----] followers, [----] engagements


"Heidelberg Pharma  ATAC: Amanitin-based Antibody Drug ConjugatePhase-1/2 ATAC3 HDP-101: BCMA HDP-102: CD37 : https://heidelberg-pharma.com/en/press-investors/announcements/press-releases-and-ad-hoc-announcements/pr-heidelberg-pharma-received-development-milestone-payment-from-partner-takeda https://heidelberg-pharma.com/en/press-investors/announcements/press-releases-and-ad-hoc-announcements/pr-heidelberg-pharma-received-development-milestone-payment-from-partner-takeda"  
[X Link](https://x.com/ADC_Chemist/status/2020468352817549403)  2026-02-08T12:02Z [----] followers, [----] engagements


"Takeda oncology pipelineHeidelberg Pharma AGADCTAK-188Phase-1/2Solid TumorsTAK-188 TAK-188anti-CCR8 ADCCCR8Treg https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C223179 https://www.takedaoncology.com/science/pipeline/utm_source=aw_sbr_paidsearch&utm_medium=cpc&utm_campaign=takonpi_corp_sem_crs_aw_sbr_nat_awa_ext&utm_keyword=takeda-oncology-pipeline&utm_id=takonpi23518&gclsrc=aw.ds&gad_source=1&gad_campaignid=20787204217&gbraid=0AAAAAqTCZsCLIhh4gLI1amjqaYTd4AKaF&gclid=Cj0KCQiAhaHMBhD2ARIsAPAU_D7M8eDUj9cwiKgymR7FDtVcsrzJ9Nr0ZERNuYho5uvh_AzHhVn_Hm0aAqeeEALw_wcB Heidelberg Pharma "  
[X Link](https://x.com/ADC_Chemist/status/2020476398201438355)  2026-02-08T12:34Z [----] followers, [----] engagements


"Heidelberg PharmaPayloadAmanitin-amanitin Heidelberg Pharma AGATACamanitin ADC https://heidelberg-pharma.com/images/managed/finanzberichte/629937ff75687_Poster_AACR_2022_1754.pdf https://heidelberg-pharma.com/images/managed/finanzberichte/629937ff75687_Poster_AACR_2022_1754.pdf"  
[X Link](https://x.com/ADC_Chemist/status/2020477575886492007)  2026-02-08T12:39Z [----] followers, [----] engagements


"202510ADCAnselamimab (AstraZeneca) Itepekimab (Sanofi/Regeneron) https://www.fiercebiotech.com/biotech/2025s-top-10-clinical-trial-flops https://www.fiercebiotech.com/biotech/2025s-top-10-clinical-trial-flops"  
[X Link](https://x.com/ADC_Chemist/status/2021009080698142945)  2026-02-09T23:51Z [----] followers, [----] engagements


"AZAZD3427AZD5462 AZD3427Phase-2dropAZD5462Phase-2b2026 https://www.fiercebiotech.com/biotech/astrazeneca-drops-heart-failure-asset-over-phase-2-efficacy-data https://www.fiercebiotech.com/biotech/astrazeneca-drops-heart-failure-asset-over-phase-2-efficacy-data"  
[X Link](https://x.com/ADC_Chemist/status/2021365371643756703)  2026-02-10T23:27Z [----] followers, [---] engagements


"Healthcare Businesswomens AssociationHBAGlobal Impact AwardHonorable Mention DSDXd ADC https://www.pharmalive.com/daiichi-sankyo-honored-with-global-impact-award-honorable-mention-by-the-hba/ https://www.pharmalive.com/daiichi-sankyo-honored-with-global-impact-award-honorable-mention-by-the-hba/"  
[X Link](https://x.com/ADC_Chemist/status/2021852940861165746)  2026-02-12T07:44Z [----] followers, [----] engagements


"BioMarinAmicus BioMarin PharmaceuticalAmicus Therapeutics49Voxzogo Voxzogo2024735004119%530%Amicus2Galafold: FabryPombiliti/Opfolda: Pompe459900203010 BiospaceBioMarin https://www.biospace.com/business/biomarin-bet-on-amicus-to-ease-voxzogos-decline-will-it-work https://www.biospace.com/business/biomarin-bet-on-amicus-to-ease-voxzogos-decline-will-it-work"  
[X Link](https://x.com/ADC_Chemist/status/2022046131132543466)  2026-02-12T20:32Z [----] followers, [----] engagements


"AGC mRNA https://bio.nikkeibp.co.jp/atcl/news/p1/26/02/06/14229/ https://bio.nikkeibp.co.jp/atcl/news/p1/26/02/06/14229/"  
[X Link](https://x.com/ADC_Chemist/status/2022237924205679018)  2026-02-13T09:14Z [----] followers, [----] engagements


"2026 Fierce 202610Fierce PharmaNovo NordiskEli Lilly2032172118 https://www.fiercepharma.com/marketing/biggest-potential-drug-launches-2026_gl=1*1nj9km3*_gcl_au*MTI2NDY0MjA1Mi4xNzY2MjIyMTc0*_ga*NTMzNTAzOTEuMTc1ODA2MjU4OQ.*_ga_KG49J84SR4*czE3NzEwMTc5NDEkbzUyJGcxJHQxNzcxMDE3OTU2JGo0NSRsMCRoMA https://www.fiercepharma.com/marketing/biggest-potential-drug-launches-2026_gl=1*1nj9km3*_gcl_au*MTI2NDY0MjA1Mi4xNzY2MjIyMTc0*_ga*NTMzNTAzOTEuMTc1ODA2MjU4OQ.*_ga_KG49J84SR4*czE3NzEwMTc5NDEkbzUyJGcxJHQxNzcxMDE3OTU2JGo0NSRsMCRoMA"  
[X Link](https://x.com/ADC_Chemist/status/2022457298443182347)  2026-02-13T23:46Z [----] followers, [---] engagements


"@Goldph GPTAI😅"  
[X Link](https://x.com/ADC_Chemist/status/2022492441816051911)  2026-02-14T02:05Z [----] followers, [---] engagements


"@Buri_goki ADCmRNADual use https://labchem-wako.fujifilm.com/jp/category/synthesis/polymer_material/peg-alternatives/index.html https://www.fujifilmpharma.com/news/fujifilm-to-establish-its-first-bio-cdmo-site-in-japan/ https://labchem-wako.fujifilm.com/jp/category/synthesis/polymer_material/peg-alternatives/index.html https://www.fujifilmpharma.com/news/fujifilm-to-establish-its-first-bio-cdmo-site-in-japan/"  
[X Link](https://x.com/ADC_Chemist/status/2022572718009520589)  2026-02-14T07:24Z [----] followers, [--] engagements


"Bolt ISACimmune-stimulating antibody conjugateBolt therapeutics trastuzumab imbotolimod [--] https://investors.boltbio.com/news-releases/news-release-details/bolt-biotherapeutics-reports-first-quarter-2024-results https://investors.boltbio.com/news-releases/news-release-details/bolt-biotherapeutics-reports-first-quarter-2024-results"  
[X Link](https://x.com/ADC_Chemist/status/1790930963989700629)  2024-05-16T02:23Z [----] followers, [----] engagements


"Thorpe-Ingold https://www.chem-station.com/odos/2014/03/-thorpe-ingold-effect.html ADCImmolative spacerTML-2Cl https://t.co/YzcYSwsuSo ADCImmolative spacer Val-Cit linkerPABC Immolative https://www.chem-station.com/odos/2014/03/-thorpe-ingold-effect.html ADCImmolative spacerTML-2Cl https://t.co/YzcYSwsuSo ADCImmolative spacer Val-Cit linkerPABC Immolative"  
[X Link](https://x.com/ADC_Chemist/status/2020100048626020682)  2026-02-07T11:39Z [----] followers, [----] engagements


"@souyakuchan IBM 🤣"  
[X Link](https://x.com/ADC_Chemist/status/2022898668475670606)  2026-02-15T05:00Z [----] followers, [---] engagements


"3 [--] [---]  https://news.yahoo.co.jp/articles/e813f7978b529b6cc11bc516c6e3ee0e81a14869 https://news.yahoo.co.jp/expert/articles/108d40e4b9d3729821168856a724e8ddf78a61a7 https://www.tokyo-np.co.jp/article/387363 https://news.yahoo.co.jp/articles/e813f7978b529b6cc11bc516c6e3ee0e81a14869 https://news.yahoo.co.jp/expert/articles/108d40e4b9d3729821168856a724e8ddf78a61a7 https://www.tokyo-np.co.jp/article/387363"  
[X Link](https://x.com/ADC_Chemist/status/1893188835007439194)  2025-02-22T06:39Z [----] followers, 674.4K engagements


"Nature Biotechnology Amgen v. Sanofi Amgen v. SanofiPCSK9 PCSK9Amgen SanofiEnablement requirement CDR Amgen vs Sanofi USPTOCDR EPO EPO USPTO CDR CDR1XCryo-EM  PK AI  https://www.nature.com/articles/s41587-024-02549-w https://www.nature.com/articles/s41587-024-02549-w"  
[X Link](https://x.com/anyuser/status/1893218424119230578)  2025-02-22T08:37Z [----] followers, 14.1K engagements


"ADC  https://t.co/s0rTFQa7Go  https://t.co/s0rTFQa7Go"  
[X Link](https://x.com/ADC_Chemist/status/1893489685726372325)  2025-02-23T02:34Z [----] followers, 20.4K engagements


"PEGPEG RNA PEG Bond flexibility ✅PEG PEGPEGPEG https://t.co/9wtxpSkzZX ✅PEG PEGPEGPEG https://t.co/9wtxpSkzZX"  
[X Link](https://x.com/ADC_Chemist/status/1897242522214429002)  2025-03-05T11:07Z [----] followers, 17.9K engagements


"PEGPEG PEG  PEGPEG PEG PEGPEG PEG PEG PEGPEG RNA PEG Bond PEGPEG RNA PEG Bond"  
[X Link](https://x.com/ADC_Chemist/status/1897244018972746064)  2025-03-05T11:13Z [----] followers, 11.5K engagements


"Merck etc IgG 9020um PEG6000NaCl [-----] [--] [---] mg/mL [---] N128 cP [---] mg/mL [--] N284 cP [---] mg/mL [----] N400 mg/mL [---] mg/mL FigGraphical Abstract https://www.sciencedirect.com/science/article/abs/pii/S0022354925000498 https://www.sciencedirect.com/science/article/abs/pii/S0022354925000498"  
[X Link](https://x.com/ADC_Chemist/status/1902563925021094200)  2025-03-20T03:32Z [----] followers, [----] engagements


"youyour youyour"  
[X Link](https://x.com/ADC_Chemist/status/1903752037411823681)  2025-03-23T10:13Z [----] followers, 10.5K engagements


"HPLCHPLC  C18 [--] 0%50%75%100%245 cm 1% TFAFAOK TLC 1% TFAMeOHDCM5 https://chemtips.wordpress.com/2012/07/12/solid-phase-synthesis-dirty-work/ https://chemtips.wordpress.com/2012/07/12/solid-phase-synthesis-dirty-work/"  
[X Link](https://x.com/ADC_Chemist/status/1906659755407622300)  2025-03-31T10:48Z [----] followers, [----] engagements


"Trastuzumab deruxtecanT-DXd T-DXd T-DXdHER2HER2-lowHER2-ultralowNature CommunicationsT-DXdHER2ADCCathepsin LCTSLDXdHER2 [--]. HER2CTSL T-DXdHER2-lowHER2-negativeHER2ADC ADCCathepsin B (CTSB) T-DXdGly-Gly-Phe-GlyCTSBCTSLCTSLpayloadDXdHER2HER2 Cathepsin LpHT-DXdHER2DXdHER2-lowHER2-ultralow [--]. Immunogenic Cell Death ICD DXdIDNA ATPHMGB1Calreticulin [--]. FcRADCP T-DXdtrastuzumabFcWild typeFcNKFcADCPpayload [--]. CD47 T-DXdCD47CD47 DXdCD47CD47SIRPDon't eat meADCPCD47CD8+T [--]. STINGTLR4 DXdHMGB1TLR4IL-6 DNAcGASSTINGIFN- CD8+T [--]. T-DXd + CD47 CD8+TCD8+T T-DX https://www.nature.com/articles/s41467-025-58266-8"  
[X Link](https://x.com/anyuser/status/1907664595856281964)  2025-04-03T05:20Z [----] followers, 19.9K engagements


"JMCEditorial Publish or perish [--] Fig [---]     CRO     perspective https://pubs.acs.org/doi/10.1021/acs.jmedchem.5c00842 https://pubs.acs.org/doi/10.1021/acs.jmedchem.5c00842"  
[X Link](https://x.com/ADC_Chemist/status/1909534018066170287)  2025-04-08T09:09Z [----] followers, [----] engagements


"ADCConjugationOA update glycan remodeling https://academic.oup.com/abt/advance-article/doi/10.1093/abt/tbaf010/8115463 https://academic.oup.com/abt/advance-article/doi/10.1093/abt/tbaf010/8115463"  
[X Link](https://x.com/ADC_Chemist/status/1914972962681442569)  2025-04-23T09:21Z [----] followers, [----] engagements


"pHProtein A Protein ApHpH [---] [--] mMpH 3.5pH7.2 Bis-Tris50 mM pH 7.2pre-elutionpH -HClpH [---]  pH [---] NaAc-HAcpH [---]  pH [---] pHpH 4.31HMW7% pH 7.272HMW HCP pH HCP500 ppm pH [---] ppm  [----] cm [--] cmpHSECCE-SDSHCP [--] cm Protein AmAb A/BFcpHProtein ApH https://www.frontiersin.org/journals/bioengineering-and-biotechnology/articles/10.3389/fbioe.2025.1567923/full https://www.frontiersin.org/journals/bioengineering-and-biotechnology/articles/10.3389/fbioe.2025.1567923/full"  
[X Link](https://x.com/ADC_Chemist/status/1919678563781116390)  2025-05-06T09:00Z [----] followers, 14.8K engagements


"DAR=1PK https://kyodonewsprwire.jp/release/202505088490 https://kyodonewsprwire.jp/release/202505088490"  
[X Link](https://x.com/ADC_Chemist/status/1920398687714619902)  2025-05-08T08:41Z [----] followers, [----] engagements


"Tween ADC 80PS80/Tween [--] PS80 TMOSUV-TMOSCOE-3PS80 : COE-3TMOSUV-TMOS PS80: PS80 PS80: PS80TMOSPS80 UV-TMOSPS80 PS80: PS80PS80 : PS80PS80PS80 PS80 https://www.sciencedirect.com/science/article/pii/S0021979724030686 https://www.sciencedirect.com/science/article/pii/S0021979724030686"  
[X Link](https://x.com/ADC_Chemist/status/1923663528684126569)  2025-05-17T08:54Z [----] followers, 13.1K engagements


"Nature Synthesis III III learning-by-building2C2'3'-N III https://www.nature.com/articles/s44160-025-00800-z https://www.nature.com/articles/s44160-025-00800-z"  
[X Link](https://x.com/ADC_Chemist/status/1925474304919318773)  2025-05-22T08:50Z [----] followers, [----] engagements


"LysTyr KRAS G12CJAK3Cys 1.7% LysTyr [--]. (Lys) 6.0%pH 7.4pKaLys [---]. PLP B6PLP IRE1ORIN1001Bcr-AblPPY-A [---]. 2- Lys [---]. 2-2-EBA N [---].  PI3KPX-866 N---L- [---]. NHSSTPSTP NHSLys in vitroLys [---]. N--N-NASA N--N-ArNASANASA BTKC481SHsp90 [---]. : NHS [---]. (VI) -SOF  -OSOF (-SOF): LysTyrSerHisXO-44Hsp72 (-OSOF): EGFRK745Aurora [--]. (Tyr) pKaPPIPPITyr [---]. in situC-CpH 2pHCBX8Y39 [---]. TAD TADLys [---]. (VI) -SOF  -OSOF Lys [---]. SufAz SufAzSuTEx: Sulfur-Triazole Exchange chemistry 124- ABPTH21150 https://pubs.acs.org/doi/10.1021/acs.chemrev.5c00001 https://pubs.acs.org/doi/10.1021/acs.chemrev.5c00001"  
[X Link](https://x.com/ADC_Chemist/status/1929118557297926429)  2025-06-01T10:11Z [----] followers, [----] engagements


"CORYNEXCorynebacterium glutamicum 3VHH https://ajibio-pharma.ajinomoto.com/jp/corynex/ https://ajibio-pharma.ajinomoto.com/jp/corynex/"  
[X Link](https://x.com/anyuser/status/1931813840758731150)  2025-06-08T20:41Z [----] followers, [----] engagements


"PEGPEG JACSOA PEGPEGPEGAPAPEG mRNAPEG APA 16EOAPA mPEG7EOAPA PEGAPA PEG(rPEG) rPEG2APA rPEGPEG PEG rPEGPEG PEGPEGlyation https://pubs.acs.org/doi/10.1021/jacs.5c02716 https://pubs.acs.org/doi/10.1021/jacs.5c02716"  
[X Link](https://x.com/ADC_Chemist/status/1934156855137452155)  2025-06-15T07:51Z [----] followers, 11.4K engagements


"ACS Med Chem LettDual-payload ADCCover articleDual https://pubs.acs.org/toc/amclct/16/7 https://pubs.acs.org/toc/amclct/16/7"  
[X Link](https://x.com/ADC_Chemist/status/1945492116311879768)  2025-07-16T14:34Z [----] followers, [----] engagements


"ScienceBakerIDR IDR  Science https://t.co/kOcU9cPxhh  Science https://t.co/kOcU9cPxhh"  
[X Link](https://x.com/ADC_Chemist/status/1947486268637778313)  2025-07-22T02:38Z [----] followers, 13.6K engagements


"@kamo_kamos @SimarakyoBanana 😆 🤭"  
[X Link](https://x.com/ADC_Chemist/status/1948534894226747756)  2025-07-25T00:04Z [----] followers, 56.6K engagements


"B2B12 Na-CMC  pH OA https://academic.oup.com/abt/article/8/3/177/8127194login=false https://academic.oup.com/abt/article/8/3/177/8127194login=false"  
[X Link](https://x.com/ADC_Chemist/status/1956635920767369525)  2025-08-16T08:35Z [----] followers, [----] engagements


"-50kg OPRDTakeda -CMO50kg CMO1500 [--] : 140165II0 :  : 105T15 MBR : 24%0IIL- - https://pubs.acs.org/doi/10.1021/acs.oprd.5c00207 https://pubs.acs.org/doi/10.1021/acs.oprd.5c00207"  
[X Link](https://x.com/ADC_Chemist/status/1959187359368610287)  2025-08-23T09:34Z [----] followers, 13.2K engagements


"NMRD Single use"  
[X Link](https://x.com/ADC_Chemist/status/1959389921283870807)  2025-08-23T22:58Z [----] followers, 29.3K engagements


":  : : 10%45%  Ni JACS AU https://pubs.acs.org/doi/full/10.1021/jacsau.5c00412 https://pubs.acs.org/doi/full/10.1021/jacsau.5c00412"  
[X Link](https://x.com/ADC_Chemist/status/1960277191868269024)  2025-08-26T09:44Z [----] followers, 31.8K engagements


": : : mCPBA1.2Kg80% Stirring Bars are Superstition  https://www.science.org/content/blog-post/stirring-bars-are-superstition https://www.science.org/content/blog-post/stirring-bars-are-superstition"  
[X Link](https://x.com/ADC_Chemist/status/1964808998466834818)  2025-09-07T21:52Z [----] followers, 18.9K engagements


"3  Bunte LADA LADALabeling-Activation-Desulfurization-Addition NCLNCysAla CysSN2/ HATH publish https://chemrxiv.org/engage/chemrxiv/article-details/68bbcf3d728bf9025eb76d59 https://chemrxiv.org/engage/chemrxiv/article-details/68bbcf3d728bf9025eb76d59"  
[X Link](https://x.com/ADC_Chemist/status/1967175931052929247)  2025-09-14T10:37Z [----] followers, 12.1K engagements


"0.000001%🤣 🤣"  
[X Link](https://x.com/ADC_Chemist/status/1975748134153150813)  2025-10-08T02:20Z [----] followers, 20.7K engagements


"MOF MOFMetalOrganic Framework MOF  : : : : MOF  MOF  MOF"  
[X Link](https://x.com/anyuser/status/1975863784611995751)  2025-10-08T10:00Z [----] followers, 21.9K engagements


"TL🤔 😅 [----] https://t.co/nx6YPk8bWB [----] https://t.co/nx6YPk8bWB"  
[X Link](https://x.com/anyuser/status/1983811031060390343)  2025-10-30T08:19Z [----] followers, 60.5K engagements


"AJICAP ADCAJICAPADC 😀 https://news.ajinomoto.co.jp/2025/10/20251031.html https://news.ajinomoto.co.jp/2025/10/20251031.html"  
[X Link](https://x.com/anyuser/status/1984197715786678642)  2025-10-31T09:56Z [----] followers, 18.3K engagements


"Antibody ConjugatesPKIn vivo imaging ADCPKIn vivo imaging [--]. PK In vivo imaging3 Conjugation ConjugationLysInterchain CysPK Site specific conjugation/TLR  DFOLumi804 / ADC payload ADCPayloadADC . Fc FcRn  https://www.nature.com/articles/s44303-025-00109-8 https://www.nature.com/articles/s44303-025-00109-8"  
[X Link](https://x.com/anyuser/status/1984558911014224028)  2025-11-01T09:51Z [----] followers, 27.1K engagements


"https://mond.how/ja/ADC_Chemist https://mond.how/ja/ADC_Chemist"  
[X Link](https://x.com/ADC_Chemist/status/1992476767878316430)  2025-11-23T06:14Z [----] followers, 10.6K engagements


"OBITROP2 ADCOBI-9921/2 OBI-992Trop-2ADC https://www.globenewswire.com/news-release/2024/06/12/2897374/0/en/OBI-Pharma-Announces-Phase-1-2-Study-Initiation-for-OBI-992-a-TROP2-Targeted-Antibody-Drug-Conjugate-ADC-for-Cancer-Therapy.html https://www.globenewswire.com/news-release/2024/06/12/2897374/0/en/OBI-Pharma-Announces-Phase-1-2-Study-Initiation-for-OBI-992-a-TROP2-Targeted-Antibody-Drug-Conjugate-ADC-for-Cancer-Therapy.html"  
[X Link](https://x.com/ADC_Chemist/status/1801134422504468756)  2024-06-13T06:08Z [----] followers, [----] engagements


"Terns PharmaceuticalsGLP-1TERN-601Phase-1284.9%Eli Lilly3.9%Pfizer5.2% https://www.biospace.com/business/terns-announces-125m-raise-on-heels-of-oral-glp-1-data-drop https://www.biospace.com/business/terns-announces-125m-raise-on-heels-of-oral-glp-1-data-drop https://www.biospace.com/business/terns-announces-125m-raise-on-heels-of-oral-glp-1-data-drop https://www.biospace.com/business/terns-announces-125m-raise-on-heels-of-oral-glp-1-data-drop"  
[X Link](https://x.com/ADC_Chemist/status/1833696691519885448)  2024-09-11T02:38Z [----] followers, [---] engagements


"Aligos TherapeuticsPhase IIaALG-05500930 https://www.biospace.com/drug-development/aligos-claims-mid-stage-win-in-mash-but-investors-are-skeptical https://www.biospace.com/drug-development/aligos-claims-mid-stage-win-in-mash-but-investors-are-skeptical"  
[X Link](https://x.com/ADC_Chemist/status/1837432607786897679)  2024-09-21T10:04Z [----] followers, [---] engagements


"ADC developerOBI Pharma Inc.GlyTech Inc.MTA : OBIGlyTechOBIGlycOBI ADC : OBIADCGlyTech OBIGlycan remodelingADC https://www.glytech-inc.com/wp-content/uploads/2024/12/20241223_glytech-news_1223_EN.pdf https://twitter.com/i/web/status/1871398528431583599 https://www.glytech-inc.com/wp-content/uploads/2024/12/20241223_glytech-news_1223_EN.pdf https://www.glytech-inc.com/wp-content/uploads/2024/12/20241223_glytech-news_1223_EN.pdf https://twitter.com/i/web/status/1871398528431583599 https://www.glytech-inc.com/wp-content/uploads/2024/12/20241223_glytech-news_1223_EN.pdf"  
[X Link](https://x.com/ADC_Chemist/status/1871398528431583599)  2024-12-24T03:32Z [----] followers, [----] engagements


"BiospacceOBI https://www.biospace.com/press-releases/obi-pharma-enters-collaboration-with-glytech-to-expand-glycobi-enabling-technologies-outreach-in-japan-and-to-advance-glycan-production https://www.biospace.com/press-releases/obi-pharma-enters-collaboration-with-glytech-to-expand-glycobi-enabling-technologies-outreach-in-japan-and-to-advance-glycan-production"  
[X Link](https://x.com/ADC_Chemist/status/1871398780777722339)  2024-12-24T03:33Z [----] followers, [---] engagements


"IGM Biosciences275%imvotamabIGM-2644 https://www.biopharmadive.com/news/igm-biosciences-imvotamab-discontinue-autoimmune-study-results/736969/ https://www.biopharmadive.com/news/igm-biosciences-imvotamab-discontinue-autoimmune-study-results/736969/"  
[X Link](https://x.com/ADC_Chemist/status/1880817364083892377)  2025-01-19T03:19Z [----] followers, [----] engagements


"Alphamab OncologyCSPC Pharmaceutical GroupCSPCHER2ADCJSKN003NMPACDEPhase-3 HER2JSKN0033Phase-3 https://www.manilatimes.net/2025/02/06/tmt-newswire/pr-newswire/anti-her2-bispecific-adc-jskn003-received-approval-to-initiate-a-phase-iii-clinical-study-for-the-treatment-of-her2-positive-breast-cancer/2050984 https://www.manilatimes.net/2025/02/06/tmt-newswire/pr-newswire/anti-her2-bispecific-adc-jskn003-received-approval-to-initiate-a-phase-iii-clinical-study-for-the-treatment-of-her2-positive-breast-cancer/2050984"  
[X Link](https://x.com/ADC_Chemist/status/1895314495888859264)  2025-02-28T03:26Z [----] followers, [----] engagements


"OBI PharmaCEO OBIGEN PHARMAFrank ChenOBI PharmaCEOHeidi WangCEOPatricia ChouIPO https://www.obipharma.com/news/new-chairman-of-obigen-pharma-obi-pharma-ceo-heidi-wang-takes-over/ https://twitter.com/i/web/status/1902292847791108594 https://www.obipharma.com/news/new-chairman-of-obigen-pharma-obi-pharma-ceo-heidi-wang-takes-over/ https://www.obipharma.com/news/new-chairman-of-obigen-pharma-obi-pharma-ceo-heidi-wang-takes-over/ https://twitter.com/i/web/status/1902292847791108594 https://www.obipharma.com/news/new-chairman-of-obigen-pharma-obi-pharma-ceo-heidi-wang-takes-over/"  
[X Link](https://x.com/ADC_Chemist/status/1902292847791108594)  2025-03-19T09:35Z [----] followers, [---] engagements


"OBIGEN Pharma2020OBI Pharma CEO"  
[X Link](https://x.com/ADC_Chemist/status/1902293089932419095)  2025-03-19T09:36Z [----] followers, [---] engagements


"Spruce BiosciencesTA-ERT Vertex PharmaceuticalsCFSpruce https://twitter.com/i/web/status/1917037503925915825 https://twitter.com/i/web/status/1917037503925915825"  
[X Link](https://x.com/ADC_Chemist/status/1917037503925915825)  2025-04-29T02:05Z [----] followers, [---] engagements


"BioMarin Inozyme Pharma2.7 BioMarin INZ-701ENPP1 BioMarin2025Q17.45+15%Voxzogo+40%2.14 31Voxzogo9 https://www.biospace.com/business/biomarin-expands-enzyme-expertise-with-270m-inozyme-buyutm_campaign=5458739-2025%20%7C%20Daily%20Social&utm_content=332967243&utm_medium=social&utm_source=linkedin&hss_channel=lcp-424124 https://www.biospace.com/business/biomarin-expands-enzyme-expertise-with-270m-inozyme-buyutm_campaign=5458739-2025%20%7C%20Daily%20Social&utm_content=332967243&utm_medium=social&utm_source=linkedin&hss_channel=lcp-424124"  
[X Link](https://x.com/ADC_Chemist/status/1923570385804722320)  2025-05-17T02:44Z [----] followers, [----] engagements


"SanofiVigil Neuroscience4.7 SanofiVigil Neuroscience470006 AbbVieAlectorTREM2SanofiVigilTREM2VG-3927 https://www.biospace.com/deals/sanofi-buys-vigil-for-470m-upfront-reigniting-a-battered-alzheimers-targetutm_campaign=5458739-2025%20%7C%20Daily%20Social&utm_content=333537582&utm_medium=social&utm_source=linkedin&hss_channel=lcp-424124 https://www.biospace.com/deals/sanofi-buys-vigil-for-470m-upfront-reigniting-a-battered-alzheimers-targetutm_campaign=5458739-2025%20%7C%20Daily%20Social&utm_content=333537582&utm_medium=social&utm_source=linkedin&hss_channel=lcp-424124"  
[X Link](https://x.com/ADC_Chemist/status/1925752493826310538)  2025-05-23T03:15Z [----] followers, 18.8K engagements


"https://x.com/Matsuda_PhDPhD/status/1925754548926185894 LecanemabLeqembiDonanemabKisunla https://x.com/Matsuda_PhDPhD/status/1925754548926185894 LecanemabLeqembiDonanemabKisunla"  
[X Link](https://x.com/ADC_Chemist/status/1925754985402261792)  2025-05-23T03:25Z [----] followers, [----] engagements


"2 SanofiVigil Neuroscience TREM2 https://x.com/Matsuda_PhDPhD/status/1925752493826310538 SanofiVigil Neuroscience4.7 https://t.co/6BJ3sPPZ4p SanofiVigil Neuroscience470006 https://x.com/Matsuda_PhDPhD/status/1925752493826310538 SanofiVigil Neuroscience4.7 https://t.co/6BJ3sPPZ4p SanofiVigil Neuroscience470006"  
[X Link](https://x.com/ADC_Chemist/status/1925755356359066064)  2025-05-23T03:27Z [----] followers, [---] engagements


"ADC & Bioconjugate East Asia 9/25-26 GeneQuantumLotteOBI PharmaPinotBioIntocellADC https://www.imapac.com/events/adc-bioconjugate-east-asia-2025utm_campaign=11292447-ADCbio2025&utm_content=339822855&utm_medium=social&utm_source=linkedin&hss_channel=lcp-1009865 https://www.imapac.com/events/adc-bioconjugate-east-asia-2025utm_campaign=11292447-ADCbio2025&utm_content=339822855&utm_medium=social&utm_source=linkedin&hss_channel=lcp-1009865"  
[X Link](https://x.com/ADC_Chemist/status/1950077690716782875)  2025-07-29T06:15Z [----] followers, [---] engagements


"LENZ TherapeuticsVIZZ VIZZFDA [----] https://www.biospace.com/press-releases/lenz-therapeutics-to-present-at-upcoming-investor-and-medical-conferences https://www.biospace.com/press-releases/lenz-therapeutics-to-present-at-upcoming-investor-and-medical-conferences https://www.biospace.com/press-releases/lenz-therapeutics-to-present-at-upcoming-investor-and-medical-conferences https://www.biospace.com/press-releases/lenz-therapeutics-to-present-at-upcoming-investor-and-medical-conferences"  
[X Link](https://x.com/ADC_Chemist/status/1960154005423927658)  2025-08-26T01:35Z [----] followers, [----] engagements


"8 Annual TPD & Induced Proximity Summit TPDArvinasC4 TherapeuticsKymera TPDHanson Wade10 https://proteindegradation.com/utm_source=digital&utm_medium=ppc&utm_campaign=brochure&utm_content=linkedin/lead-gen/audience/ev-55430 https://proteindegradation.com/utm_source=digital&utm_medium=ppc&utm_campaign=brochure&utm_content=linkedin/lead-gen/audience/ev-55430"  
[X Link](https://x.com/ADC_Chemist/status/1961380809832804455)  2025-08-29T10:50Z [----] followers, [---] engagements


"OBI PharmaAP BiosciencesADC AP BiosciencesOBI PharmaADC https://www.obipharma.com/news/obi-pharma-and-ap-biosciences-sign-technology-collaboration-agreement/ https://www.obipharma.com/news/obi-pharma-and-ap-biosciences-sign-technology-collaboration-agreement/"  
[X Link](https://x.com/ADC_Chemist/status/1963435381086732507)  2025-09-04T02:54Z [----] followers, [---] engagements


"Immunome Inc.ADCPayloadHC74ADC I ADC  https://www.businesswire.com/news/home/20251023619001/en/Immunome-Presents-Preclinical-Data-Showing-Proprietary-TOP1i-ADC-Payload-HC74-Overcomes-Multiple-Mechanisms-of-ADC-Resistance https://www.businesswire.com/news/home/20251023619001/en/Immunome-Presents-Preclinical-Data-Showing-Proprietary-TOP1i-ADC-Payload-HC74-Overcomes-Multiple-Mechanisms-of-ADC-Resistance https://www.businesswire.com/news/home/20251023619001/en/Immunome-Presents-Preclinical-Data-Showing-Proprietary-TOP1i-ADC-Payload-HC74-Overcomes-Multiple-Mechanisms-of-ADC-Resistance"  
[X Link](https://x.com/ADC_Chemist/status/1982053264477892929)  2025-10-25T11:54Z [----] followers, [----] engagements


"OBI PharmaADCOBI-902FDA (Cholangiocarcinoma) Trop2DAR=4Topo1iADC OBIGlycOBIconjugation https://www.obipharma.com/news/obi-902-has-been-granted-by-us-fda-for-odd/ https://twitter.com/i/web/status/1990012360409636928 https://www.obipharma.com/news/obi-902-has-been-granted-by-us-fda-for-odd/ https://www.obipharma.com/news/obi-902-has-been-granted-by-us-fda-for-odd/ https://twitter.com/i/web/status/1990012360409636928 https://www.obipharma.com/news/obi-902-has-been-granted-by-us-fda-for-odd/"  
[X Link](https://x.com/ADC_Chemist/status/1990012360409636928)  2025-11-16T11:01Z [----] followers, [----] engagements


"PinotbioPhase-2ADC Celltrion https://www.pinotbio.com/en/ https://www.pinotbio.com/en/"  
[X Link](https://x.com/ADC_Chemist/status/2003133156229349818)  2025-12-22T15:58Z [----] followers, [----] engagements


"JPM [----] TPDSustainable Margin TransformationEvopointADC https://newsroom.astellas.com/JPM-2026-Pioneering-science-to-change-tomorrowutm_source=LinkedIn&utm_medium=organic&utm_campaign=announcement&utm_content=25-L-149&sf230489790=1 https://newsroom.astellas.com/JPM-2026-Pioneering-science-to-change-tomorrowutm_source=LinkedIn&utm_medium=organic&utm_campaign=announcement&utm_content=25-L-149&sf230489790=1 https://newsroom.astellas.com/JPM-2026-Pioneering-science-to-change-tomorrowutm_source=LinkedIn&utm_medium=organic&utm_campaign=announcement&utm_content=25-L-149&sf230489790=1"  
[X Link](https://x.com/ADC_Chemist/status/2010667208821912043)  2026-01-12T10:56Z [----] followers, [----] engagements


"OBI PharmaTegMine TherapeuticsADC OBI PharmaTegMine TherapeuticsADCTegMineOBIObrion ADCGlycOBIEndoSymeOBIHYPrOBIADCOBI https://twitter.com/i/web/status/2011206904400454109 https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/obi-pharma-and-tegmine-therapeutics-sign-exclusive-global-license-agr-1126261 https://twitter.com/i/web/status/2011206904400454109 https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/obi-pharma-and-tegmine-therapeutics-sign-exclusive-global-license-agr-1126261"  
[X Link](https://x.com/ADC_Chemist/status/2011206904400454109)  2026-01-13T22:41Z [----] followers, [---] engagements


"BMSSan DiegoJanux TherapeuticsT-Cell engager JanuxTMETCE BMS50008 https://www.biospace.com/deals/bms-bets-850m-on-januxs-tumor-activated-drugs-deepening-cancer-investments https://www.biospace.com/deals/bms-bets-850m-on-januxs-tumor-activated-drugs-deepening-cancer-investments https://www.biospace.com/deals/bms-bets-850m-on-januxs-tumor-activated-drugs-deepening-cancer-investments https://www.biospace.com/deals/bms-bets-850m-on-januxs-tumor-activated-drugs-deepening-cancer-investments"  
[X Link](https://x.com/ADC_Chemist/status/2014488252200165495)  2026-01-23T00:00Z [----] followers, [----] engagements


"Johnson & Johnson J&JShockwave Medical : 2254.3% :Stelara (ustekinumab): 294.9% Darzalex (daratumumab): 2921% 2024: J&J20248928966.1%6.6% Shockwave Medical: 20244Shockwave Medical131 Rybrevant (amivantamab-vmjw) + Lazertinib: EGFR Tremfya (guselkumab): IRA : CMSJ&J StelaraXarelto: IRAJ&J https://twitter.com/i/web/status/1814217622667604114 https://www.biospace.com/business/touting-shockwaves-billion-dollar-potential-j-j-lifts-2024-guidanceutm_campaign=2024%20%7C%20Daily%20Social&utm_content=300780033&utm_medium=social&utm_source=linkedin&hss_channel=lcp-424124"  
[X Link](https://x.com/ADC_Chemist/status/1814217622667604114)  2024-07-19T08:36Z [----] followers, [---] engagements


"Aardvark TherapeuticsHelicoreMetsera Aardvark Therapeutics9408IPO Helicore6500Versant Ventures Metsera28900IPO https://twitter.com/i/web/status/1890323780792381752 https://www.biospace.com/business/aardvark-therapeutics-gets-94-million-ipo-to-power-obesity-treatmentsutm_campaign=5458739-2025%20%7C%20Daily%20Social&utm_content=324675079&utm_medium=social&utm_source=linkedin&hss_channel=lcp-424124 https://twitter.com/i/web/status/1890323780792381752"  
[X Link](https://x.com/ADC_Chemist/status/1890323780792381752)  2025-02-14T08:54Z [----] followers, [---] engagements


"CRO CDMONitto Denko AveciaAgilent TechnologiesNitto Denko Avecia25 https://twitter.com/i/web/status/1908804909040013606 https://twitter.com/i/web/status/1908804909040013606"  
[X Link](https://x.com/ADC_Chemist/status/1908804909040013606)  2025-04-06T08:52Z [----] followers, 12.2K engagements


"Spruce Biosciences55 BioMarinMPS IIIBtralesinidase alfaTA-ERT [--] TA-ERTBLA [-------] [-------------] https://www.biospace.com/job-trends/spruce-axes-55-of-staff-leaving-shoestring-crew-to-focus-on-new-rare-disease-assetutm_campaign=5458739-2025%20%7C%20Daily%20Social&utm_content=331365441&utm_medium=social&utm_source=linkedin&hss_channel=lcp-424124 https://www.biospace.com/job-trends/spruce-axes-55-of-staff-leaving-shoestring-crew-to-focus-on-new-rare-disease-assetutm_campaign=5458739-2025%20%7C%20Daily%20Social&utm_content=331365441&utm_medium=social&utm_source=linkedin&hss_channel=lcp-424124"  
[X Link](https://x.com/ADC_Chemist/status/1917036850117808533)  2025-04-29T02:02Z [----] followers, [----] engagements


"5 Eli LillyZepboundNovo NordiskWegovy5 [--]. TERN-601Terns Pharmaceuticals : GLP-1Phase-1284.9% : Terns Pharmaceuticals [--]. DanuglipronPfizer : GLP-1 : 1273%50%11 [--]. CT-173Roche/Carmot Therapeutics : PYY : Carmot [--]. AMG 786Amgen : : MariTide [--]. AzelapragBioAge Labs : : Phase-211 https://twitter.com/i/web/status/1960268941361816033 https://www.biospace.com/drug-development/weight-loss-wasteland-5-obesity-assets-that-failedutm_campaign=5458739-2025%20%7C%20Daily%20Social&utm_content=344778673&utm_medium=social&utm_source=linkedin&hss_channel=lcp-424124"  
[X Link](https://x.com/ADC_Chemist/status/1960268941361816033)  2025-08-26T09:11Z [----] followers, [----] engagements


"BioMarin PharmaceuticalAmicus https://www.biospace.com/business/biomarin-pumps-up-revenue-goals-with-4-8b-amicus-purchase https://www.biospace.com/business/biomarin-pumps-up-revenue-goals-with-4-8b-amicus-purchase"  
[X Link](https://x.com/ADC_Chemist/status/2002712495090438246)  2025-12-21T12:07Z [----] followers, [----] engagements


"https://www.biomarin.com/news/press-releases/biomarin-to-acquire-amicus-therapeutics-for-4-8-billion-expanding-position-as-a-leader-in-rare-diseases-accelerating-revenue-growth-and-strengthening-financial-outlook/ https://www.biomarin.com/news/press-releases/biomarin-to-acquire-amicus-therapeutics-for-4-8-billion-expanding-position-as-a-leader-in-rare-diseases-accelerating-revenue-growth-and-strengthening-financial-outlook/"  
[X Link](https://x.com/ADC_Chemist/status/2002712496671752593)  2025-12-21T12:07Z [----] followers, [---] engagements


"PD-1/VEGFAkesoSummit TherapeuticsivonescimabKeytruda Phase-3PD-L1TPS 1%NSCLC398ivonescimabKeytrudaPFSivonescimabKeytruda49% https://twitter.com/i/web/status/2010809967780278718 https://www.fiercepharma.com/pharma/akeso-summit-pd-1-bispecific-crushes-merck-keytruda-new-standard-lung-cancer https://twitter.com/i/web/status/2010809967780278718 https://www.fiercepharma.com/pharma/akeso-summit-pd-1-bispecific-crushes-merck-keytruda-new-standard-lung-cancer"  
[X Link](https://x.com/ADC_Chemist/status/2010809967780278718)  2026-01-12T20:23Z [----] followers, [---] engagements


"Xtandi202760M&A M&AM&A CLDN18.2VyloyASP2138EvopointADC 5VyloyPadcevXospataIzervayVeozahXtandiPadcev28-35ADC https://www.fiercepharma.com/pharma/astellas-ceo-resists-rescue-bd-6b-xtandi-patent-cliff-nears_gl=1*o55m5f*_gcl_au*MTI2NDY0MjA1Mi4xNzY2MjIyMTc0*_ga*NTMzNTAzOTEuMTc1ODA2MjU4OQ.*_ga_KG49J84SR4*czE3Njg1MTU5OTckbzI3JGcxJHQxNzY4NTE1OTk3JGo2MCRsMCRoMA"  
[X Link](https://x.com/ADC_Chemist/status/2011930537385214313)  2026-01-15T22:36Z [----] followers, [----] engagements


"Bolt BiotherapeuticsCaprin-1ISAC Bolt BiotherapeuticsCaprin-1Caprin-1ISACADCBoltBoltbodyADCCaprin-1TRK-950Boltbody TRK-950 2017Phase-1 2022Phase-1 [----] Phase-2 https://twitter.com/i/web/status/1889600304007766407 https://investors.boltbio.com/news-releases/news-release-details/bolt-biotherapeutics-inc-provides-update-global-cancer https://twitter.com/i/web/status/1889600304007766407 https://investors.boltbio.com/news-releases/news-release-details/bolt-biotherapeutics-inc-provides-update-global-cancer"  
[X Link](https://x.com/ADC_Chemist/status/1889600304007766407)  2025-02-12T08:59Z [----] followers, [----] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing